Editorial R. F. W. Moulds
  • 1 December 2004
Editorial

The need for new drugs: a response

Judith A. Whitworth
  • 1 December 2004
Letters to the Editor

Quality use of medicines - prescribing for manufacturers or patients?

Mike Hobbs
  • 1 December 2004
Letters to the Editor

Thiazolidinediones

Derek Grubb, Jerry R. Greenfield, Donald J. Chisholm
  • 1 December 2004
Letters to the Editor

Antibiotic prescribing

Nancy Sturman, John Ferguson
  • 1 December 2004
Article

The vascular effects of COX-2 selective inhibitors

Richard O. Day, Garry G Graham
  • 1 December 2004
Article

Are atypical antipsychotics advantageous? - the case for

Nicholas A. Keks
  • 1 December 2004
Article

Perioperative analgesia

Stephan A. Schug, Philip Dodd
  • 1 December 2004
Feature

Drugs and breastfeeding 2004 guide.

Jane Talbot
  • 1 December 2004
Feature

Analgesics for the elderly

  • 1 December 2004
Article

What does TGA approval of medicines mean?

John McEwen
  • 1 December 2004
Feature

Pocket guide to chest X-rays

Lindy Viviers
  • 1 December 2004
Feature

Health care and notions of risk

Janette Donovan
  • 1 December 2004
Letters to the Editor

Insulin glargine

James Robertson
  • 1 December 2004
Letters to the Editor

Warfarin: balancing the benefits and harms

T. Hodson, Marija Borosak, Shin Choo, Alison Street
  • 1 December 2004
NEW DRUGS

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe